KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $30.5 million.

  • Resmed's Net Cash Flow fell 7551.79% to $30.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $848.9 million, marking a year-over-year increase of 15369.85%. This contributed to the annual value of $945.3 million for FY2025, which is 765527.11% up from last year.
  • As of Q4 2025, Resmed's Net Cash Flow stood at $30.5 million, which was down 7551.79% from $174.5 million recorded in Q3 2025.
  • Resmed's Net Cash Flow's 5-year high stood at $402.8 million during Q1 2025, with a 5-year trough of -$81.4 million in Q4 2021.
  • In the last 5 years, Resmed's Net Cash Flow had a median value of $18.8 million in 2022 and averaged $57.8 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first crashed by 45416.31% in 2023, then soared by 7479627.33% in 2025.
  • Resmed's Net Cash Flow (Quarter) stood at -$81.4 million in 2021, then surged by 143.15% to $35.1 million in 2022, then crashed by 120.69% to -$7.3 million in 2023, then soared by 1811.28% to $124.4 million in 2024, then plummeted by 75.52% to $30.5 million in 2025.
  • Its Net Cash Flow stands at $30.5 million for Q4 2025, versus $174.5 million for Q3 2025 and $241.2 million for Q2 2025.